Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > S. Charles Ryan > Profile

S. Charles Ryan

Affiliations

  • President at Quince Therapeutics Inc. (QNCX), 2025-06-23
  • Large Shareholder, Director at Neurotrope Inc. (NTRP), 2020-12-04
  • Director at Applied Dna Sciences Inc (APDN), 2019-05-21
  • Director at Biorestorative Therapies Inc. (BRTX), 2019-03-25
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
QNCX $0.65 48,387 $31,451.55 122,461 2024-08-20 Filing
BRTX $4.00 6,250 $25,000.00 16,250 2015-12-07 Filing
BRTX $0.25 200,000 $50,000.00 200,000 2015-05-08 Filing